Why the study?
Aortic arch plaques are linked to increased cardiovascular morbidity and mortality, but few studies have evaluated plaque progression and contributing risk factors using transthoracic echocardiography in older adults.
What is the rate of aortic arch plaque progression and its risk factors in older adults assessed by sequential transthoracic echocardiography?
What is the rate of aortic arch plaque progression and its risk factors in older adults assessed by sequential transthoracic echocardiography?
Sequential transthoracic echocardiography demonstrates a high incidence of aortic arch plaque progression in older adults, particularly among those with little to no plaque at baseline.
Answers are grounded in this paper and cite their sources.
AAP progression common in older adults with minimal baseline plaque; hypothesis-generating for serial TTE risk stratification pending prospective studies.
Background and aims: The presence of aortic arch plaques (AAP) is significantly associated with increased cardiovascular morbidity and mortality. Few studies have examined the incidence of AAP progression and factors which may contribute to it using transthoracic echocardiography (TTE). The objective of this study was to utilize sequential imaging of the aortic arch using TTE to examine the rate of AAP progression and its risk factors in a cohort of older adults. Methods: Participants enrolled in both the Cardiovascular Abnormalities and Brain Lesion study (years 2005-2010) and the Subclinical Atrial Fibrillation and Risk of Ischemic Stroke study (2014-2019) who underwent TTE with assessment of aortic arch plaques at both time points represent the study cohort. Results: 300 participants were included in the study. Mean age was 67.8 ± 7.5 years at baseline, and 76.7 ± 6.8 years at follow-up; 197 (65.7%) were women. At baseline, 87 (29%) had no significant AAP, 182 (60.7%) had evidence of small AAP (2.0-3.9 mm) and 31 (10.3%) had evidence of large (≥4 mm) AAP. At the time of follow-up assessment, 157 (52.3%) of participants exhibited progression of AAP with 70 (23.3%) having mild progression and 87 (29%) having severe progression. There were no significant demographic or clinical predictors of AAP progression except baseline plaque thickness itself which was significantly lower in the group with AAP progression. Conclusions: Our study demonstrates a high prevalence of AAP on TTE exam in a population-based cohort of older adults with a high incidence of AAP progression. TTE is a useful test for baseline and follow up imaging of AAP, even in subjects with no or little AAP at baseline.
No takes yet. Share an insight, caveat, or question.
Leibowitz et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: